COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study

COVID-19 appears to put people living with HIV and AIDS (PLWHA) at a higher risk of catastrophic consequences and mortality. However, investigations on the hesitancy and vaccination behavior of PLWHA in China were lacking compared to the general population. From January 2022 to March 2022, we conduc...

Full description

Bibliographic Details
Main Authors: Xuan Lv, Chaobo Zhao, Bing Song, Huihuang Huang, Su Song, Hai Long, Weidong Liu, Min Du, Min Liu, Jue Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2151798
_version_ 1797673139174375424
author Xuan Lv
Chaobo Zhao
Bing Song
Huihuang Huang
Su Song
Hai Long
Weidong Liu
Min Du
Min Liu
Jue Liu
author_facet Xuan Lv
Chaobo Zhao
Bing Song
Huihuang Huang
Su Song
Hai Long
Weidong Liu
Min Du
Min Liu
Jue Liu
author_sort Xuan Lv
collection DOAJ
description COVID-19 appears to put people living with HIV and AIDS (PLWHA) at a higher risk of catastrophic consequences and mortality. However, investigations on the hesitancy and vaccination behavior of PLWHA in China were lacking compared to the general population. From January 2022 to March 2022, we conducted a multi-center cross-sectional survey of PLWHA in China. Logistic regression models were used to examine factors associated to vaccine hesitancy and COVID-19 vaccine uptake. Among 1424 participants, 108 participants (7.6%) were hesitant to be vaccinated while 1258 (88.3%) had already received at least one dose of the COVID-19 vaccine. Higher COVID-19 vaccine hesitancy was associated with older age, a lower academic level, chronic disease, lower CD4+ T cell counts, severe anxiety and despair, and high perception of illness. Lower education level, lower CD4+ T cell counts, and significant anxiety and depression were all associated with a lower vaccination rate. When compared to vaccinated participants, those who were not hesitant but nevertheless unvaccinated had a higher presence of chronic disease and lower CD4+ T cell count. Tailored interventions (e.g. targeted education programs) based on these linked characteristics were required to alleviate concerns for PLWHA in promoting COVID-19 vaccination rates, particularly for PLWHA with lower education levels, lower CD4+ T cell counts, and severe anxiety and depression.
first_indexed 2024-03-11T21:40:09Z
format Article
id doaj.art-d5e8735086324d3290c4118a68d52a34
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:40:09Z
publishDate 2023-01-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-d5e8735086324d3290c4118a68d52a342023-09-26T13:25:46ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-01-0119110.1080/21645515.2022.21517982151798COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional studyXuan Lv0Chaobo Zhao1Bing Song2Huihuang Huang3Su Song4Hai Long5Weidong Liu6Min Du7Min Liu8Jue Liu9Peking UniversityPeking UniversityNational Clinical Research Center for Infectious DiseasesNational Clinical Research Center for Infectious DiseasesGuiyang Public Health Clinical CenterGuiyang Public Health Clinical CenterThe Fourth People’s Hospital of DatongPeking UniversityPeking UniversityPeking UniversityCOVID-19 appears to put people living with HIV and AIDS (PLWHA) at a higher risk of catastrophic consequences and mortality. However, investigations on the hesitancy and vaccination behavior of PLWHA in China were lacking compared to the general population. From January 2022 to March 2022, we conducted a multi-center cross-sectional survey of PLWHA in China. Logistic regression models were used to examine factors associated to vaccine hesitancy and COVID-19 vaccine uptake. Among 1424 participants, 108 participants (7.6%) were hesitant to be vaccinated while 1258 (88.3%) had already received at least one dose of the COVID-19 vaccine. Higher COVID-19 vaccine hesitancy was associated with older age, a lower academic level, chronic disease, lower CD4+ T cell counts, severe anxiety and despair, and high perception of illness. Lower education level, lower CD4+ T cell counts, and significant anxiety and depression were all associated with a lower vaccination rate. When compared to vaccinated participants, those who were not hesitant but nevertheless unvaccinated had a higher presence of chronic disease and lower CD4+ T cell count. Tailored interventions (e.g. targeted education programs) based on these linked characteristics were required to alleviate concerns for PLWHA in promoting COVID-19 vaccination rates, particularly for PLWHA with lower education levels, lower CD4+ T cell counts, and severe anxiety and depression.http://dx.doi.org/10.1080/21645515.2022.2151798covid-19hivvaccine hesitancyvaccination rate
spellingShingle Xuan Lv
Chaobo Zhao
Bing Song
Huihuang Huang
Su Song
Hai Long
Weidong Liu
Min Du
Min Liu
Jue Liu
COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
Human Vaccines & Immunotherapeutics
covid-19
hiv
vaccine hesitancy
vaccination rate
title COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
title_full COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
title_fullStr COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
title_full_unstemmed COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
title_short COVID-19 vaccination in people living with HIV and AIDS (PLWHA) in China: A cross-sectional study
title_sort covid 19 vaccination in people living with hiv and aids plwha in china a cross sectional study
topic covid-19
hiv
vaccine hesitancy
vaccination rate
url http://dx.doi.org/10.1080/21645515.2022.2151798
work_keys_str_mv AT xuanlv covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT chaobozhao covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT bingsong covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT huihuanghuang covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT susong covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT hailong covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT weidongliu covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT mindu covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT minliu covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy
AT jueliu covid19vaccinationinpeoplelivingwithhivandaidsplwhainchinaacrosssectionalstudy